Randy Milby - Jan 14, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Stock symbol
THAR
Transactions as of
Jan 14, 2022
Transactions value $
$19,635
Form type
4
Date filed
1/20/2022, 08:26 AM
Previous filing
Jan 20, 2022
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THAR Common Stock Conversion of derivative security $25.9K +8.1K +0.34% $3.20* 2.43M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $36.2K +11.3K +0.47% $3.20* 2.44M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $10.3K +3.23K +0.13% $3.20* 2.44M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $36.9K +11.5K +0.47% $3.20* 2.45M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $92.9K +29K +1.18% $3.20* 2.48M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $90.8K +28.4K +1.14% $3.20* 2.51M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $61.7K +19.3K +0.77% $3.20* 2.53M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $30.8K +9.64K +0.38% $3.20* 2.54M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $71.7K +22.4K +0.88% $3.20* 2.56M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $113K +35.2K +1.37% $3.20* 2.6M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $84.2K +26.3K +1.01% $3.20* 2.62M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $30.6K +9.57K +0.37% $3.20* 2.63M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $99.9K +31.2K +1.19% $3.20* 2.66M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $99.4K +31.1K +1.17% $3.20* 2.69M Jan 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THAR Convertible Note Conversion of derivative security -$25K 0 Jan 14, 2022 Common stock 8.1K $3.20 Direct F1
transaction THAR Convertible Note Conversion of derivative security -$35K 0 Jan 14, 2022 Common stock 11.3K $3.20 Direct F2
transaction THAR Convertible Note Conversion of derivative security -$10K 0 Jan 14, 2022 Common stock 3.23K $3.20 Direct F3
transaction THAR Convertible Note Conversion of derivative security -$35.8K 0 Jan 14, 2022 Common stock 11.5K $3.20 Direct F4
transaction THAR Convertible Note Conversion of derivative security -$90K 0 Jan 14, 2022 Common stock 29K $3.20 Direct F5
transaction THAR Convertible Note Conversion of derivative security -$88K 0 Jan 14, 2022 Common stock 28.4K $3.20 Direct F6
transaction THAR Convertible Note Conversion of derivative security -$60K 0 Jan 14, 2022 Common stock 19.3K $3.20 Direct F7
transaction THAR Convertible Note Conversion of derivative security -$30K 0 Jan 14, 2022 Common stock 9.64K $3.20 Direct F8
transaction THAR Convertible Note Conversion of derivative security -$70K 0 Jan 14, 2022 Common stock 22.4K $3.20 Direct F9
transaction THAR Convertible Note Conversion of derivative security -$110K 0 Jan 14, 2022 Common stock 35.2K $3.20 Direct F10
transaction THAR Convertible Note Conversion of derivative security -$82.5K 0 Jan 14, 2022 Common stock 26.3K $3.20 Direct F11
transaction THAR Convertible Note Conversion of derivative security -$30.3K 0 Jan 14, 2022 Common stock 9.57K $3.20 Direct F12
transaction THAR Convertible Note Conversion of derivative security -$99K 0 Jan 14, 2022 Common stock 31.2K $3.20 Direct F13
transaction THAR Convertible Note Conversion of derivative security -$99K 0 Jan 14, 2022 Common stock 31.1K $3.20 Direct F14
transaction THAR Options (right to purchase) Award $0 +758K $0.00 758K Jan 14, 2022 Common stock 758K $4.00 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 19, 2021, the Registrant issued the Reporting Person a $25,000 note which matures on the earlier of (i) April 19, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F2 On April 30, 2021, the Registrant issued the Reporting Person a $35,000 note which matures on the earlier of (i) April 30, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F3 On May 10, 2021, the Registrant issued the Reporting Person a $10,000 note which matures on the earlier of (i) May 10, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon shall converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F4 On May 15, 2021, the Registrant issued the Reporting Person a $35,750 note which matures on the earlier of (i) May 15, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F5 On May 25, 2021, the Registrant issued the Reporting Person a $90,000 note which matures on the earlier of (i) May 25, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F6 On May 29, 2021, the Registrant issued the Reporting Person an $88,000 note which matures on the earlier of (i) May 29, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F7 On June 14, 2021, the Registrant issued the Reporting Person a $59,990 note which matures on the earlier of (i) June 14, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F8 On June 22, 2021, the Registrant issued the Reporting Person a $30,000 note which matures on the earlier of (i) June 22, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F9 On July 16, 2021, the Registrant issued the Reporting Person a $70,000 note which matures on the earlier of (i) July 17, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F10 On July 28, 2021, the Registrant issued the Reporting Person a $110,000 note which matures on the earlier of (i) July 28, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F11 On August 13, 2021, the Registrant issued the Reporting Person an $82,500 note which matures on the earlier of (i) August 13, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F12 On October 14, 2021, the Registrant issued the Reporting Person a $30,250 note which matures on the earlier of (i) October 14, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F13 On November 12, 2021, the Registrant issued the Reporting Person a $99,000 note which matures on the earlier of (i) November 12, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F14 On December 15, 2021, the Registrant issued the Reporting Person a $99,000 note which matures on the earlier of (i) December 15, 2024 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F15 The Registrant issued the Reporting Person options on January 14, 2022. The options vest over a 48 month period commencing 12 months after the date of grant.

Remarks:

This is the third of the Form 4s.